Stocks and Investing
Stocks and Investing
Fri, February 16, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Danielle Antalffy Maintained (ATRC) at Strong Buy with Increased Target to $58 on, Feb 16th, 2024
Danielle Antalffy of UBS, Maintained "AtriCure, Inc." (ATRC) at Strong Buy with Increased Target from $57 to $58 on, Feb 16th, 2024.
Danielle has made no other calls on ATRC in the last 4 months.
There are 2 other peers that have a rating on ATRC. Out of the 2 peers that are also analyzing ATRC, 0 agree with Danielle's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Danielle
- Daniel Stauder of "JMP Securities" Reiterated at Buy and Held Target at $60 on, Wednesday, November 29th, 2023
- Robbie Marcus of "JP Morgan" Maintained at Buy with Decreased Target to $50 on, Thursday, November 2nd, 2023
Contributing Sources